Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × inavolisib × Breast × Clear all

Phase

Phase 2 8 Phase 3 2 Phase 2/3 1 Phase 1/2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Capecitabine 14 Paclitaxel 13 Docetaxel 11 Cyclophosphamide 10 Epirubicin 8 Carboplatin 8 Trastuzumab 7 Letrozole 6 Gemcitabine 6 Doxorubicin 6 pertuzumab 5 exemestane 3 Vinorelbine 3 Lapatinib 3 Cisplatin 3 AC protocol 3 pyrotinib 2 palbociclib 2 Zoledronic Acid 2 Thiotepa 2 Taxes 2 Tamoxifen 2 Neoadjuvant Therapy 2 Melatonin 2 Fulvestrant 2 Fluorouracil 2 Exercise 2 Drug Therapy 2 Albumin-Bound Paclitaxel 2 Ado-Trastuzumab Emtansine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04191499 2026-03-17

INAVO120

Hoffmann-La Roche

Phase 2/3 Active not recruiting

325 enrolled 14 charts 1 FDA

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡